Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Wan-Hsin Wen"'
Publikováno v:
Pediatrics and Neonatology, Vol 65, Iss 2, Pp 202-203 (2024)
Externí odkaz:
https://doaj.org/article/35f1e060dad24b1c94e72301cce71892
Autor:
Wan-Hsin Wen, 文萬欣
101
Hepatitis B virus (HBV) infection is a serious health problem worldwide. Since the launch of the universal immunization program, the seropositive rate of hepatitis B surface antigen (HBsAg) and the incidence rates of related complications in
Hepatitis B virus (HBV) infection is a serious health problem worldwide. Since the launch of the universal immunization program, the seropositive rate of hepatitis B surface antigen (HBsAg) and the incidence rates of related complications in
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/89772206280829267738
Autor:
Wan-Hsin Wen, 文萬欣
93
Since the nationwide hepatitis B vaccination program was launched in 1984, the seropositive rate of hepatitis surface antigen (HBsAg), the incidence/mortality rate of fulminant hepatitis and the incidence rate of hepatocellular carcinoma in T
Since the nationwide hepatitis B vaccination program was launched in 1984, the seropositive rate of hepatitis surface antigen (HBsAg), the incidence/mortality rate of fulminant hepatitis and the incidence rate of hepatocellular carcinoma in T
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/33022818864444696643
Publikováno v:
Best Practice & Research Clinical Obstetrics & Gynaecology. 68:54-65
Women at childbearing age and pregnant ladies living in the areas of high or intermediate prevalence of hepatitis B virus (HBV) remain at risk of getting the infection and passing the infections to their offspring via mother-to-child transmission (MT
Autor:
C. P. Chen, Y. H. Lin, H. H. Lin, Hong-Yuan Hsu, J. J. Hu, K. C. Chang, Y. K. Chang, T. H. Su, Y. C. Chiu, C. K. Yang, Wan-Hsin Wen, M. S. Tsai, H. Y. Chiueh, H. L. Hwa, D. S. Chen, Huey-Ling Chen, F. S. Peng, Ming-Kwang Shyu, Lu Lu Zhao, L. H. Lin, C. L. Lee, Shu Chi Mu, K. H. Chao, P. J. Cheng, K. H. Chen, Ming Wei Lai, Y. C. Lin, C. L. Hsieh, S. M. Chen, J. C. Shih, T. H. Wang, C. C. Lin, W. R. Yang, B. H. Lau, P. Y. Lin, J. P. Huang, Mei-Hwei Chang, Jia-Feng Wu, C. Y. Yeung, H. S. Pan, Tiffany Ting-Fang Shih, J. J. Hsu, C. J. Liu, B. Q. She, Y. L. Chang, H. J. Chen, Yen-Hsuan Ni, L. M. Lo, Y. N. Su, Yi-Ching Tung, S. W. Cheng, Chien-Nan Lee
Publikováno v:
Journal of Hepatology. 72:1082-1087
Background & Aims Tenofovir disoproxil fumarate (TDF) is the preferred treatment to prevent maternal transmission of HBV, owing to its efficacy and safety. However, data are lacking on the long-term safety outcomes in children following fetal exposur
Autor:
Hong Yuan, Hsu, Huey Ling, Chen, Cheng Lun, Chiang, Ming Wei, Lai, Shu Chi, Mu, Wan Hsin, Wen, Shao Wen, Cheng, Jen Jan, Hu, Kai Chi, Chang, Chien Nan, Lee, Chun Jen, Liu, Jia Feng, Wu, Yen Hsuan, Ni, Mei Hwei, Chang
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
Maternal tenofovir disoproxil fumarate (TDF) therapy during late pregnancy can reduce mother-to-infant transmission of hepatitis B virus (HBV). We investigated HBV mutations associated with maternal TDF therapy and their role in infant immunonophylax
Autor:
Lung-Huang Lin, Yu-En Chiu, Chien-Nan Lee, Chun-Jen Liu, Huey-Ling Chen, Mei-Hwei Chang, Huai-Lung Chang, Wan-Hsin Wen
Publikováno v:
Journal of viral hepatitisREFERENCES. 29(2)
Tenofovir disoproxil fumarate (TDF) is the preferred treatment to prevent mother-to-infant transmission in highly viremic HBV-infected women. Data on hepatitis B surface antigen (HBsAg) levels in pregnant women are lacking. We aimed to investigate pr
Autor:
Kai-Chi, Chang, Mei-Hwei, Chang, Chien-Nan, Lee, Chin-Hao, Chang, Jia-Feng, Wu, Yen-Hsuan, Ni, Wan-Hsin, Wen, Ming-Kwang, Shyu, Ming-Wei, Lai, Shih-Ming, Chen, Jen-Jan, Hu, Hans Hsienhong, Lin, Jenn-Jeih, Hsu, Shu-Chi, Mu, Yu-Cheng, Lin, Chun-Jen, Liu, Ding-Shinn, Chen, Lung-Huang, Lin, Huey-Ling, Chen, Ching-Feng, Huang
Publikováno v:
Alimentary Pharmacology & Therapeutics. 50:306-316
BACKGROUND Maternal anti-viral treatment prevents mother-to-infant transmission of hepatitis B virus (HBV), but the role of neonatal viremia on subsequent HBV infection is not clear. AIMS To investigate the effect of maternal anti-viral treatment on
Autor:
Hong-Yuan Hsu, Huey-Ling Chen, Jia-Feng Wu, Yen-Hsuan Ni, Kai-Chi Chang, Cheng-Lun Chiang, Chien-Nan Lee, Lu-Lu Zhao, Ming-Wei Lai, Shu-Chi Mu, Wan-Hsin Wen, Lung-Huang Lin, Mei-Hwei Chang, Shyu MK, Hwa HL, Su YN, Shih JC, Chao KH, Chiu YC, Liu CJ, Su TH, Chen DS, Chen SM, Lin CC, Lin PY, Yang WR, Hu JJ, Yang CK, Chang YK, Chen KH, Lin HH, Lin YH, Chen HJ, Pan HS, Lau BH, Lee CL, Cheng PJ, Chang YL, Chiueh HY, Wang TH, Hsu JJ, Lo LM, Hsieh CL, Cheng SW, Tsai MS, She BQ, Peng FS, Lin YC, Chen CP, Huang JP, Yeung CY
Publikováno v:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 19(7)
Tenofovir disoproxil fumurate (TDF) therapy during late pregnancy in highly viremic mothers can reduce residual overt hepatitis B virus (HBV) infections of their infants that occur despite immunoprophylaxis.1,2 Occult HBV infection (OBI) has been def
Publikováno v:
The Journal of Infectious Diseases. 216:S785-S791
Hepatitis B virus (HBV) immunization has been effectively preventing chronic HBV infection with >90% efficacy in countries with universal neonatal immunization. Perinatal mother-to-infant transmission of HBV remains the major cause of chronic HBV inf